Top Banner
Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics
21

Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Dec 29, 2015

Download

Documents

Norma Watts
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Non-stimulant Behavioral MedsA Staff Coffee Potpourri

Edward J. Coll, LTC(P), MC

Chief, Developmental Pediatrics

Page 2: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

The Usual Suspects

Methylphenidate

Dextroamphetamine

Racemic amphetamine mixture (Adderal)

Pemoline (Cylert)

Page 3: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Methylphenidate

Short, intermediate, long-acting options– rule of 3’s

Ritalin = Brand Name– Focus-in on The Simpsons

Sprinkles: Metadate CD Hard capsule, osmotic pump: Concerta d-threo-methylphenidate: Focalin

Page 4: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

d-amphetamine

Short, intermediate options– rule of 3’s

Dexedrine = Brand Name– tablet, sprinkles

Sprinkles: Dexedrine spansules 1st used, but now 3rd place

– still good meds

Page 5: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

d-amphetamine/dl-amphetamineAdderal

Intermediate, long acting

Tablet: intermediate

Sprinkles/capsule: Adderal XR

Page 6: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Atomoxetine

Selective norepinephrine uptake inhibitor Little effect on dopamine or serotonin

uptake Little effect on Ach, H1, alpha-2, DA

receptors Well-tolerated in adult studies

Page 7: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Atomoxetine…AD/HD…Randomized, Placebo-Controlled, Dose-Response...

297 children and adolescents 8-18 years old; 71 % male 70% had prior stimulant therapy Combined/Inattentive/Hyper-impulsive 63/33/2 % 37 % Oppositional-defiant disorder 1 depression, 1 anxiety disorder

Atomoxetine…AD/HD…Study. Pediatrics 108:e83, 2001

Page 8: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Doses Measured

0.5 mg/kg/d div BID 1.2 mg/kg/d div BID 1.8 mg/kg/d div BID

– < highest studied doses in adults

8 week period

Atomoxetine…AD/HD…Study. Pediatrics 108:e83, 2001

Page 9: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Measures: Behavioral

Parent rating only, not school Interviewer ADHD rating scale (ADHD RS) Parent ADHD rating scale (Conners’) Clinical Global Impressions of Severity Childhood Depression Rating Scale Child Health Questionnaire

Atomoxetine…AD/HD…Study. Pediatrics 108:e83, 2001

Page 10: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Measures: Physiologic

Cytochrome P450 2D6 category– extensive vs– poor metabolizers (7% of US population)

#6 in placebo group, 11 in atomoxetine group

Side effects Heart rate, BP, EKG analysis, weight change

Atomoxetine…AD/HD…Study. Pediatrics 108:e83, 2001

Page 11: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Conclusions

Well tolerated at all doses (1.2 = 1.8 mg/kg) Superior to placebo in most measures

– all core AD/HD measures BP, pulse changes similar to methylphenidate

studies Dose-dependent weight loss Poor metabolizers had comparable response

– small sample size–

Atomoxetine…AD/HD…Study. Pediatrics 108:e83, 2001

Page 12: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Open-label study 30 7-14 year olds; 89% with comorbid dx 0.25-1.9 mg/kg/day divided BID 11 week titration 39% reduction in ADHD interview scores 29 % reduction in CGI-ADHD-S rhinitis 33%, headache 20%, anorexia 16.7%,

dizziness 16.7%–

J of Child and Adolescent Psychopharm 2001; 11:521-265

Page 13: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Directions

1st Study extends to one year

Recruiting for study of ADHD + tic disorders Comparison to stimulant

– e.g. Concerta vs TID methylphenidate Best role in AD/HD comorbid management

– antidepressant properties–

Page 14: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil (ProVigil)

A non-stimulant stimulant Narcolepsy, daytime drowsiness in... Mechanism ?

– Alter balance of GABA and glutamate which activates the hypothalamus

– Increases metabolic rate of amygdala and hippocampus

– activates hypocretin(orexin)-containing neurons, (which are disrupted in narcolepsy)

Page 15: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil in AD/HDOpen-label study

11 5-15 years old, M:F = 9:6 started Combined/inattentive/hyper-impulsive 12/2/1 started

– 2 noncompliant with protocol– 1 hand-foot-mouth disease– 1 adverse rxn: episodic hand tremor + MS change

very mixed bag of comorbidities: PDD, TS...

J of Am Acad of Child and Adol Psychiatry 2001; 40:230-235

Page 16: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil in AD/HDOpen-label study

AD/HD measures– Conners’ Parent and Teacher– ADHD Rating Scale IV for Parent and Teacher– Test of Variables of Attention (TOVA)

Side effects Vital signs, weight

J of Am Acad of Child and Adol Psychiatry 2001; 40:230-235

Page 17: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil in AD/HDOpen-label study

Once daily dosing

Start 100 mg titrated to maximum 400 mg

Length of time avg 4.6 weeks (range 2-7 wks)

J of Am Acad of Child and Adol Psychiatry 2001; 40:230-235

Page 18: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil in AD/HDOpen-label study

AM dose effect into afternoon Improved Conners’ and ADHD Rating Scales Improved TOVA impulsivity scores

– but not inattention scores Delayed sleep (3), stomachache, headache,

lightheadedness, tremors, finger-biting (1)

J of Am Acad of Child and Adol Psychiatry 2001; 40:230-235

Page 19: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil BE AWAKE all you can be!

WRAIR

3 doses of modafinil vs 600 mg caffeine Performance testing in sleep deprivation Enhances performance and alertness No advantages over caffeine

Psychopharmacology (Berl) 2002 Jan;159(3):238-47

Page 20: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Modafinil BE AWAKE all you can be!

Aeromedical Research Lab., Ft. Rucker, AL Aviator alertness and performance 6 pilots, 40 hour wakeful periods compared Placebo vs 3 x 200 mg modafinil 4/6 performance measures improved, reduced

slow wave EEG, better mood, alertness side effects: vertigo, nausea, dizziness

Psychopharmacology (Berl) 2000 Jun;150(3):272-82

Page 21: Non-stimulant Behavioral Meds A Staff Coffee Potpourri Edward J. Coll, LTC(P), MC Chief, Developmental Pediatrics.

Asleep at the Throttle